Publikationen

Veröffentlichungsjahr: 2018
Testbiotech comment on “Scientific Opinion on application (EFSA-GMO-DE-2011-95) for the placing on the market of genetically modified maize 5307" from Syngenta
2018
PDF icon Testbiotech_Comment_Maize 5307.pdf
Differences: Genome editing and mutagenesis
2018
PDF icon Table_comparison CRISPR & mutagenesis.pdf
Unterschiede: Genome Editing und Mutagenese
Testbiotech Basis-Text
2018
PDF icon Tabelle Vergleich CRISPR & Mutagenese.pdf
Legal analysis: The genome editing technique is covered by Directive 2001/18
Comment on Advocate Bobeks Opinion in case C-528/16
Professor Ludwig Kraemer
2018
PDF icon Legal dossier_GMO - genome editing_2018.pdf
Testbiotech on risk assessment of Golden Rice by FSANZ (February 2018)
2018
PDF icon Testbiotech on risk assessment of Golden Rice by FSANZ_Preliminary Version.pdf
Testbiotech comment on EFSA GMO Panel Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (EFSA-GMO-RX-004)
2018
PDF icon TBT comment MS8 x RF3_2018.pdf
Testbiotech comment on EFSA´s opinion on the assessment of genetically modified maize 1507 x 59122 x MON810 x NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2011-92) by company DowDuPont
2018
PDF icon Testbiotech_Comment_Maize 1507_59122_MON810_NK603.pdf
Veröffentlichungsjahr: 2017
Testbiotech comment on ‘Scientific Opinion on application EFSA-GMO-BE-2013-118 for authorisation of genetically modified maize MON 87427 x MON 89034 x 1507 x MON 88017 x 59122 and subcombinations
2017
PDF icon Testbiotech_Comment_Maize MON 87427 x MON 89034 x 1507 x MON 88017 x 59122.pdf
Testbiotech comment on ‘Scientific Opinion on application EFSA-GMO-BE-2013-117 for authorisation of genetically modified maize MON 87427 × MON 89034 × NK603 and subcombinations by Monsanto (September 2017)
2017
PDF icon Testbiotech_Comment_Maize MON 87427 × MON 89034 × NK603 .pdf
Eingabe von Testbiotech (Juli 2017)
Antwort auf den Brief des Patentinhabers vom 29.11. 2016 und die Stellungnahme der Einspruchsabteilung vom 27.01.2017
2017
PDF icon Antwort auf MPG_Testbiotech.pdf

Seiten